Takeda Pharmaceuticals U.s.a., Inc. - Net Worth and Insider Trading

Over the past 18 months, Takeda Pharmaceuticals U.s.a., Inc. made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc (QNCX) were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceuticals U.s.a., Inc. made no insider transaction in Myovant Sciences Ltd (MYOV). Other recent insider transactions involving Myovant Sciences Ltd (MYOV) include a net sale of 4,051 shares made by Matthew Lang , a net sale of 3,360 shares made by Ferreira Juan Camilo Arjona , and a net purchase of 51,599,200 shares made by Sumitomo Chemical Co., Ltd. .

In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,697 shares of Myovant Sciences Ltd (MYOV) were sold and 51,599,200 shares were bought by its insiders, resulting in a net purchase of 51,579,503 shares.

Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceuticals U.s.a., Inc. made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 4,505,319 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 0 shares of Molecular Templates Inc (MTEM) in total and bought 250,000 shares, with a net purchase of 250,000 shares. During the past 18 months, 0 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net purchase of 533,688 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceuticals U.s.a., Inc. made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 126,607 shares made by Samuel C. Blackman , a net sale of 83,857 shares made by Jeremy Bender , and a net sale of 56,236 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 85,781 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 85,781 shares. During the past 18 months, 374,613 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,870,071 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Pharmaceuticals U.s.a., Inc. made no insider transaction in Ovid Therapeutics Inc (OVID). Other recent insider transactions involving Ovid Therapeutics Inc (OVID) include a net purchase of 18,248 shares made by Jeremy M Levin ,

In summary, during the past 3 months, insiders sold 0 shares of Ovid Therapeutics Inc (OVID) in total and bought 18,248 shares, with a net purchase of 18,248 shares. During the past 18 months, 0 shares of Ovid Therapeutics Inc (OVID) were sold and 18,248 shares were bought by its insiders, resulting in a net purchase of 18,248 shares.

Ovid Therapeutics Inc (OVID)'s detailed insider trading history can be found in Insider Trading Tracker table.